• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大麻素受体信号转导的神经生物学

Neurobiology of cannabinoid receptor signaling
.

机构信息

Institute of Physiological Chemistry, University Medical Center of the Johannes Gutenberg University, Mainz, Germany.

出版信息

Dialogues Clin Neurosci. 2020 Sep;22(3):207-222. doi: 10.31887/DCNS.2020.22.3/blutz.

DOI:10.31887/DCNS.2020.22.3/blutz
PMID:33162764
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7605026/
Abstract

The endocannabinoid system (ECS) is a highly versatile signaling system within the nervous system. Despite its widespread localization, its functions within the context of distinct neural processes are very well discernable and specific. This is remarkable, and the question remains as to how such specificity is achieved. One key player in the ECS is the cannabinoid type 1 receptor (CB), a G protein-coupled receptor characterized by the complexity of its cell-specific expression, cellular and subcellular localization, and its adaptable regulation of intracellular signaling cascades. CB receptors are involved in different synaptic and cellular plasticity processes and in the brain's bioenergetics in a context-specific manner. CB receptors are also important in several processes in neurons, glial cells, and immune cells of the brain. As polymorphisms in ECS components, as well as external impacts such as stress and metabolic challenges, can both lead to dysregulated ECS activity and subsequently to possible neuropsychiatric disorders, pharmacological intervention targeting the ECS is a promising therapeutic approach. Understanding the neurobiology of cannabinoid receptor signaling in depth will aid optimal design of therapeutic interventions, minimizing unwanted side effects.
.

摘要

内源性大麻素系统 (ECS) 是神经系统内一种高度多样化的信号转导系统。尽管其广泛定位,但在不同神经过程的背景下,其功能非常明显且具有特异性。这是非常显著的,问题仍然是如何实现这种特异性。ECS 中的一个关键参与者是大麻素 1 型受体 (CB),它是一种 G 蛋白偶联受体,其特征是细胞特异性表达、细胞和亚细胞定位以及其对细胞内信号级联的适应性调节的复杂性。CB 受体参与不同的突触和细胞可塑性过程,并以特定于上下文的方式参与大脑的生物能量学。CB 受体在神经元、神经胶质细胞和大脑免疫细胞中的几个过程中也很重要。由于 ECS 成分的多态性以及应激和代谢挑战等外部影响都可能导致 ECS 活性失调,进而导致可能的神经精神疾病,因此针对 ECS 的药物干预是一种有前途的治疗方法。深入了解大麻素受体信号的神经生物学将有助于优化治疗干预措施的设计,最大限度地减少不良反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5996/7605026/5b3a005c46da/DCNS_22.3_Lutz_Figure3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5996/7605026/69145e708a21/DCNS_22.3_Lutz_Figure1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5996/7605026/27da2e26a29c/DCNS_22.3_Lutz_Figure2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5996/7605026/5b3a005c46da/DCNS_22.3_Lutz_Figure3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5996/7605026/69145e708a21/DCNS_22.3_Lutz_Figure1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5996/7605026/27da2e26a29c/DCNS_22.3_Lutz_Figure2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5996/7605026/5b3a005c46da/DCNS_22.3_Lutz_Figure3.jpg

相似文献

1
Neurobiology of cannabinoid receptor signaling
.大麻素受体信号转导的神经生物学
Dialogues Clin Neurosci. 2020 Sep;22(3):207-222. doi: 10.31887/DCNS.2020.22.3/blutz.
2
An Introduction to the Endogenous Cannabinoid System.内源性大麻素系统简介。
Biol Psychiatry. 2016 Apr 1;79(7):516-25. doi: 10.1016/j.biopsych.2015.07.028. Epub 2015 Oct 30.
3
The Role of the Endocannabinoid System in the Brain-Gut Axis.内源性大麻素系统在脑-肠轴中的作用。
Gastroenterology. 2016 Aug;151(2):252-66. doi: 10.1053/j.gastro.2016.04.015. Epub 2016 Apr 29.
4
The implication of CNR1 gene's polymorphisms in the modulation of endocannabinoid system effects.CNR1基因多态性在调节内源性大麻素系统效应中的意义。
Rom J Intern Med. 2009;47(1):9-18.
5
Cannabinoid Receptor Modulation of Neurogenesis: ST14A Striatal Neural Progenitor Cells as a Simplified In Vitro Model.大麻素受体对神经发生的调节:ST14A 纹状体神经祖细胞作为一种简化的体外模型。
Molecules. 2021 Mar 7;26(5):1448. doi: 10.3390/molecules26051448.
6
Cannabinoid receptors and endocannabinoids: evidence for new players.大麻素受体与内源性大麻素:新角色的证据
AAPS J. 2006 Apr 28;8(2):E298-306. doi: 10.1007/BF02854900.
7
Role of the endocannabinoid system in drug addiction.内源性大麻素系统在药物成瘾中的作用。
Biochem Pharmacol. 2018 Nov;157:108-121. doi: 10.1016/j.bcp.2018.09.013. Epub 2018 Sep 12.
8
ENDOCANNABINOIDS RECEPTORS MEDIATED CENTRAL AND PERIPHERAL EFFECTS (REVIEW).内源性大麻素受体介导的中枢和外周效应(综述)
Georgian Med News. 2020 Jan(298):137-143.
9
Anandamide receptor signal transduction.花生四烯乙醇胺受体信号转导。
Vitam Horm. 2009;81:79-110. doi: 10.1016/S0083-6729(09)81004-2.
10
Endocannabinoid system: emerging role from neurodevelopment to neurodegeneration.内源性大麻素系统:从神经发育到神经退行性变的新作用
Mini Rev Med Chem. 2009 Apr;9(4):448-62. doi: 10.2174/138955709787847921.

引用本文的文献

1
Acute cannabis intoxication among the paediatric population.儿科人群中的急性大麻中毒。
Front Toxicol. 2025 Apr 14;7:1558721. doi: 10.3389/ftox.2025.1558721. eCollection 2025.
2
Editorial: Use of cannabis derivatives in veterinary medicine.社论:大麻衍生物在兽医学中的应用。
Front Vet Sci. 2025 Mar 7;12:1539422. doi: 10.3389/fvets.2025.1539422. eCollection 2025.
3
Medicinal Cannabis and the Intestinal Microbiome.药用大麻与肠道微生物群

本文引用的文献

1
Glucose metabolism links astroglial mitochondria to cannabinoid effects.葡萄糖代谢将星形胶质细胞的线粒体与大麻素的作用联系起来。
Nature. 2020 Jul;583(7817):603-608. doi: 10.1038/s41586-020-2470-y. Epub 2020 Jul 8.
2
VF-13, a chimeric peptide of VD-hemopressin(α) and neuropeptide VF, produces potent antinociception with reduced cannabinoid-related side effects.VF-13 是 VD-hemopressin(α)和神经肽 VF 的嵌合肽,具有强大的镇痛作用,且减少了与大麻素相关的副作用。
Neuropharmacology. 2020 Sep 15;175:108178. doi: 10.1016/j.neuropharm.2020.108178. Epub 2020 Jun 13.
3
Brain organoids: an ensemble of bioassays to investigate human neurodevelopment and disease.
Pharmaceuticals (Basel). 2024 Dec 17;17(12):1702. doi: 10.3390/ph17121702.
4
Growth hormone secretagogue receptor and cannabinoid receptor type 1 intersection in the mouse brain.小鼠大脑中生长激素促分泌素受体与1型大麻素受体的交叉作用
Brain Struct Funct. 2024 Dec 19;230(1):15. doi: 10.1007/s00429-024-02876-3.
5
Cannabis, Endocannabinoids and Brain Development: From Embryogenesis to Adolescence.大麻、内源性大麻素与大脑发育:从胚胎发生到青春期。
Cells. 2024 Nov 13;13(22):1875. doi: 10.3390/cells13221875.
6
A comprehensive review of natural compounds and their structure-activity relationship in Parkinson's disease: exploring potential mechanisms.帕金森病中天然化合物及其构效关系的综合综述:探索潜在机制
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar;398(3):2229-2258. doi: 10.1007/s00210-024-03462-4. Epub 2024 Oct 11.
7
Endocannabinoid system and phytocannabinoids in the main species of veterinary interest: a comparative review.内源性大麻素系统和植物大麻素在主要具有兽医应用价值的物种中的应用:比较综述。
Vet Res Commun. 2024 Oct;48(5):2915-2941. doi: 10.1007/s11259-024-10509-7. Epub 2024 Aug 20.
8
Potential of CBD Acting on Cannabinoid Receptors CB and CB in Ischemic Stroke.CBD 对缺血性脑卒中 CB1 和 CB2 受体作用的潜力。
Int J Mol Sci. 2024 Jun 18;25(12):6708. doi: 10.3390/ijms25126708.
9
Cannabinoid Analgesia in Postoperative Pain Management: From Molecular Mechanisms to Clinical Reality.大麻素类药物在术后疼痛管理中的应用:从分子机制到临床现实。
Int J Mol Sci. 2024 Jun 6;25(11):6268. doi: 10.3390/ijms25116268.
10
Assessing the effectiveness of cannabidiol additive supplementation on canine behavior and cortisol levels.评估大麻二酚添加剂补充剂对犬类行为和皮质醇水平的有效性。
Heliyon. 2024 May 15;10(10):e31345. doi: 10.1016/j.heliyon.2024.e31345. eCollection 2024 May 30.
脑类器官:一套用于研究人类神经发育和疾病的生物检测组合。
Cell Death Differ. 2021 Jan;28(1):52-67. doi: 10.1038/s41418-020-0566-4. Epub 2020 Jun 1.
4
Positive Allosteric Modulation of CB Cannabinoid Receptor Signaling Enhances Morphine Antinociception and Attenuates Morphine Tolerance Without Enhancing Morphine- Induced Dependence or Reward.CB大麻素受体信号的正向变构调节增强吗啡镇痛作用并减轻吗啡耐受性,而不增强吗啡诱导的依赖性或奖赏效应。
Front Mol Neurosci. 2020 Apr 28;13:54. doi: 10.3389/fnmol.2020.00054. eCollection 2020.
5
Endocannabinoid System Components as Potential Biomarkers in Psychiatry.内源性大麻素系统成分作为精神病学中的潜在生物标志物
Front Psychiatry. 2020 Apr 27;11:315. doi: 10.3389/fpsyt.2020.00315. eCollection 2020.
6
Discovery of a NAPE-PLD inhibitor that modulates emotional behavior in mice.发现一种 NAPE-PLD 抑制剂,可调节小鼠的情绪行为。
Nat Chem Biol. 2020 Jun;16(6):667-675. doi: 10.1038/s41589-020-0528-7. Epub 2020 May 11.
7
Advances in the discovery of fatty acid amide hydrolase inhibitors: what does the future hold?脂肪酸酰胺水解酶抑制剂的发现进展:未来如何?
Expert Opin Drug Discov. 2020 Jul;15(7):765-778. doi: 10.1080/17460441.2020.1751118. Epub 2020 Apr 15.
8
Cerebrospinal fluid endocannabinoid levels in Gilles de la Tourette syndrome.抽动秽语综合征患者脑脊液中内源性大麻素水平
Neuropsychopharmacology. 2020 Jul;45(8):1323-1329. doi: 10.1038/s41386-020-0671-6. Epub 2020 Apr 9.
9
RecV recombinase system for in vivo targeted optogenomic modifications of single cells or cell populations.RecV 重组酶系统用于活体内单细胞或细胞群体的靶向光遗传学修饰。
Nat Methods. 2020 Apr;17(4):422-429. doi: 10.1038/s41592-020-0774-3. Epub 2020 Mar 23.
10
Potential application of endocannabinoid system agents in neuropsychiatric and neurodegenerative diseases-focusing on FAAH/MAGL inhibitors.内源性大麻素系统药物在神经精神疾病和神经退行性疾病中的潜在应用——聚焦于脂肪酸酰胺水解酶/单酰甘油脂肪酶抑制剂
Acta Pharmacol Sin. 2020 Oct;41(10):1263-1271. doi: 10.1038/s41401-020-0385-7. Epub 2020 Mar 18.